Shoulder Innovations, Inc. (SI) Revenue, Earnings & Financial Statements
$20.64NYSE: SIMarket Cap $431.83M
Data as of Nov 16, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Shoulder Innovations, Inc. most recently reported annual revenue of $47.0M, a net loss of $40.0M. Revenue grew at an average annual rate of 57.3% over the last 2 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Shoulder Innovations, Inc.: Revenue rose from $19.0M in 2023 to $47.0M in 2025, a change of +147.4% over 2 years; net profit was positive in 0 of 3 reported years; operating margin moved from -56.4% to -55.6%, a shift of +0.8 percentage points; the most recent year shows a net loss of $40.0M.
Income Statement — 3 Years (USD millions)
Metric
2023
2024
2025
Revenue
$19.0M
$32.0M
$47.0M
Operating Expenses
$30.0M
$46.0M
$74.0M
Operating Profit
−$11.0M
−$15.0M
−$26.0M
Operating Margin
-56.4%
-46.3%
-55.6%
Other Income
−$2.0M
−$1.0M
−$14.0M
Interest
$1.0M
$1.0M
$0
Depreciation
$2.0M
$2.0M
$3.0M
Profit Before Tax
−$13.0M
−$16.0M
−$40.0M
Tax rate (%)
0.0%
0.0%
0.0%
Net Profit
−$13.0M
−$16.0M
−$40.0M
EPS
−$0.63
−$0.77
−$1.96
Quarterly Results — Last 12 Quarters (USD millions)
3 duplicate period labels in the source data were collapsed.
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$7.0M
$7.0M
$8.0M
$7.0M
$9.0M
$10.0M
$11.0M
$12.0M
$14.0M
$17.0M
$17.0M
$16.0M
Operating Expenses
$9.0M
$10.0M
$12.0M
$11.0M
$12.0M
$14.0M
$17.0M
$19.0M
$23.0M
$26.0M
$27.0M
$24.0M
Operating Profit
−$2.0M
−$3.0M
−$4.0M
−$4.0M
−$4.0M
−$4.0M
−$6.0M
−$8.0M
−$8.0M
−$9.0M
−$10.0M
−$8.0M
Operating Margin
-35.2%
-45.3%
-48.2%
-52.1%
-40.5%
-42.4%
-53.2%
-65.0%
-59.0%
-53.7%
-58.4%
-46.9%
Interest
$1.0M
$0
$0
$0
$0
$0
$0
$0
$1.0M
$0
$0
$1.0M
Profit Before Tax
−$3.0M
−$4.0M
−$4.0M
−$4.0M
−$4.0M
−$5.0M
−$19.0M
−$9.0M
−$8.0M
−$8.0M
−$10.0M
−$7.0M
Tax rate (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Net Profit
−$3.0M
−$4.0M
−$4.0M
−$4.0M
−$4.0M
−$5.0M
−$19.0M
−$9.0M
−$8.0M
−$8.0M
−$10.0M
−$7.0M
EPS
−$0.13
−$0.18
−$0.21
−$0.20
−$0.19
−$0.23
−$0.95
−$0.43
−$0.38
−$0.41
−$0.49
−$0.34
Over the 3 years reported for Shoulder Innovations, Inc., borrowings increased from $14.0M in 2023 to $15.0M in 2025, cash stood at $27.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 11.21 times.
Balance Sheet — 3 Years (USD millions)
Metric
2023
2024
2025
Total Assets
$54.0M
$43.0M
$170.0M
Current Assets
$48.0M
$35.0M
$157.0M
Cash
$6.0M
$6.0M
$27.0M
Inventory
$10.0M
$14.0M
$22.0M
Receivables
$5.0M
$5.0M
$8.0M
Fixed Assets
$6.0M
$8.0M
$13.0M
Capital Work in Progress
$0
$0
$0
Investments
$27.0M
$9.0M
$97.0M
Other Assets
$0
$0
$0
Total Liabilities
$94.0M
$98.0M
$29.0M
Current Liabilities
$4.0M
$8.0M
$14.0M
Borrowings
$14.0M
$15.0M
$15.0M
Other Liabilities
$80.0M
$83.0M
$14.0M
Equity
$0
$0
$0
Reserves
−$40.0M
−$55.0M
$141.0M
For Shoulder Innovations, Inc., operating cash flow was positive in 0 of 3 reported years; free cash flow in the latest year was negative at $36.0M; free cash flow was positive in 0 of 3 years.
Cash Flow Statement — 3 Years (USD millions)
Metric
2023
2024
2025
Operating Cash Flow
−$13.0M
−$14.0M
−$29.0M
Investing Cash Flow
−$32.0M
$10.0M
−$103.0M
Financing Cash Flow
$0
$0
$0
Net Cash Flow
$3.0M
$0
$21.0M
Free Cash Flow
−$16.0M
−$18.0M
−$36.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.71
EV / EBITDA
-12.34
FCF Yield
-11.68%
Quick Ratio
8.92
Interest Coverage
37.04
Return 1Y
40.75%
Return 3Y
—
Return 5Y
—
Shoulder Innovations, Inc. (SI) financials — frequently asked questions
What is Shoulder Innovations, Inc.'s annual revenue?
Shoulder Innovations, Inc. (SI) reported annual revenue of $47.0M in its most recent fiscal year.
What is Shoulder Innovations, Inc.'s net profit?
Shoulder Innovations, Inc. (SI) reported a net loss of $40.0M in its most recent fiscal year.
What is SI EV/EBITDA?
Shoulder Innovations, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -12.34. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.
Revenue and earnings of other Medical - Specialties stocks